Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene

Senquan Liu, Zhaohui Ye, Yongxing Gao, Chaoxia He, Donna W. Williams, Alison Moliterno, Jerry Spivak, He Huang, Linzhao Cheng

Research output: Contribution to journalArticle

Abstract

Activating point mutations in the MPL gene encoding the thrombopoietin receptor are found in 3%–10% of essential thrombocythemia (ET) and myelofibrosis patients. Here, we report the derivation of induced pluripotent stem cells (iPSCs) from an ET patient with a heterozygous MPL V501L mutation. Peripheral blood CD34+ progenitor cells were reprogrammed by transient plasmid expression of OCT4, SOX2, KLF4, c-MYC plus BCL2L1 (BCL-xL) genes. The derived line M494 carries a MPL V501L mutation, displays typical iPSC morphology and characteristics, are pluripotent and karyotypically normal. Upon differentiation, the iPSCs are able to differentiate into cells derived from three germ layers.

Original languageEnglish (US)
Pages (from-to)57-59
Number of pages3
JournalStem Cell Research
Volume18
DOIs
StatePublished - Jan 1 2017

Fingerprint

Essential Thrombocythemia
Induced Pluripotent Stem Cells
Mutation
Genes
Thrombopoietin Receptors
Germ Layers
Primary Myelofibrosis
Point Mutation
Plasmids
Stem Cells

ASJC Scopus subject areas

  • Medicine(all)
  • Developmental Biology
  • Cell Biology

Cite this

Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene. / Liu, Senquan; Ye, Zhaohui; Gao, Yongxing; He, Chaoxia; Williams, Donna W.; Moliterno, Alison; Spivak, Jerry; Huang, He; Cheng, Linzhao.

In: Stem Cell Research, Vol. 18, 01.01.2017, p. 57-59.

Research output: Contribution to journalArticle

Liu, Senquan; Ye, Zhaohui; Gao, Yongxing; He, Chaoxia; Williams, Donna W.; Moliterno, Alison; Spivak, Jerry; Huang, He; Cheng, Linzhao / Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.

In: Stem Cell Research, Vol. 18, 01.01.2017, p. 57-59.

Research output: Contribution to journalArticle

@article{2f35209a7728488e9e8eba900b3ab29a,
title = "Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene",
abstract = "Activating point mutations in the MPL gene encoding the thrombopoietin receptor are found in 3%–10% of essential thrombocythemia (ET) and myelofibrosis patients. Here, we report the derivation of induced pluripotent stem cells (iPSCs) from an ET patient with a heterozygous MPL V501L mutation. Peripheral blood CD34+ progenitor cells were reprogrammed by transient plasmid expression of OCT4, SOX2, KLF4, c-MYC plus BCL2L1 (BCL-xL) genes. The derived line M494 carries a MPL V501L mutation, displays typical iPSC morphology and characteristics, are pluripotent and karyotypically normal. Upon differentiation, the iPSCs are able to differentiate into cells derived from three germ layers.",
author = "Senquan Liu and Zhaohui Ye and Yongxing Gao and Chaoxia He and Williams, {Donna W.} and Alison Moliterno and Jerry Spivak and He Huang and Linzhao Cheng",
year = "2017",
month = "1",
doi = "10.1016/j.scr.2016.12.012",
volume = "18",
pages = "57--59",
journal = "Stem Cell Research",
issn = "1873-5061",
publisher = "Elsevier",

}

TY - JOUR

T1 - Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene

AU - Liu,Senquan

AU - Ye,Zhaohui

AU - Gao,Yongxing

AU - He,Chaoxia

AU - Williams,Donna W.

AU - Moliterno,Alison

AU - Spivak,Jerry

AU - Huang,He

AU - Cheng,Linzhao

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Activating point mutations in the MPL gene encoding the thrombopoietin receptor are found in 3%–10% of essential thrombocythemia (ET) and myelofibrosis patients. Here, we report the derivation of induced pluripotent stem cells (iPSCs) from an ET patient with a heterozygous MPL V501L mutation. Peripheral blood CD34+ progenitor cells were reprogrammed by transient plasmid expression of OCT4, SOX2, KLF4, c-MYC plus BCL2L1 (BCL-xL) genes. The derived line M494 carries a MPL V501L mutation, displays typical iPSC morphology and characteristics, are pluripotent and karyotypically normal. Upon differentiation, the iPSCs are able to differentiate into cells derived from three germ layers.

AB - Activating point mutations in the MPL gene encoding the thrombopoietin receptor are found in 3%–10% of essential thrombocythemia (ET) and myelofibrosis patients. Here, we report the derivation of induced pluripotent stem cells (iPSCs) from an ET patient with a heterozygous MPL V501L mutation. Peripheral blood CD34+ progenitor cells were reprogrammed by transient plasmid expression of OCT4, SOX2, KLF4, c-MYC plus BCL2L1 (BCL-xL) genes. The derived line M494 carries a MPL V501L mutation, displays typical iPSC morphology and characteristics, are pluripotent and karyotypically normal. Upon differentiation, the iPSCs are able to differentiate into cells derived from three germ layers.

UR - http://www.scopus.com/inward/record.url?scp=85028040643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028040643&partnerID=8YFLogxK

U2 - 10.1016/j.scr.2016.12.012

DO - 10.1016/j.scr.2016.12.012

M3 - Article

VL - 18

SP - 57

EP - 59

JO - Stem Cell Research

T2 - Stem Cell Research

JF - Stem Cell Research

SN - 1873-5061

ER -